Is Novo Nordisk A S Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSE: NVO) stock is to Strong Buy NVO stock.
Out of 1 analyst, 1 (100%) are recommending NVO as a Strong Buy, 0 (0%) are recommending NVO as a Buy, 0 (0%) are recommending NVO as a Hold, 0 (0%) are recommending NVO as a Sell, and 0 (0%) are recommending NVO as a Strong Sell.
What is NVO's forecast return on equity (ROE) for 2023-2026?
(NYSE: NVO) forecast ROE is N/A, which is considered weak.
What is NVO's Price Target?
According to 1 Wall Street analyst that have issued a 1 year NVO price target, the average NVO price target is $15.50, with the highest NVO stock price forecast at $15.50 and the lowest NVO stock price forecast at $15.50.
The Wall Street analyst predicted that Novo Nordisk A S's share price could fall to $15.50 by Mar 28, 2024. The average Novo Nordisk A S stock price prediction forecasts a potential downside of 83.02% from the current NVO share price of $91.30.
What is NVO's forecast return on assets (ROA) for 2023-2026?
(NYSE: NVO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.07%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.